Back to Trials
NCT07490197Recruiting

Acute Subdural Hematoma

Methodist Health System

Start Date

2/1/2026

Completion Date

2/1/2028

Summary

This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.

Detailed Description

The primary objective of this study is to establish a data repository permissive of quality improvement studies/observations specific to patients with Acute Subdural Hematoma and evaluate impact of surgical interventions like burr hole trephination, Craniotomy, Decompressive Craniectomy, and Middle Meningeal Arteryembolization embolization on survival outcomes.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * ≥18 years old * Included in the Methodist Dallas Medical Center Trauma Registry * Acute subdural hematoma identified on computed tomography scan or magnetic resonance imaging of the brain in the trauma bay within 72 hours of a traumatic event Exclusion Criteria: * \<18 years old * Prisoners, pregnant persons, or other protected population

Interventions

OTHER

Medical/Phenotype Data Collection Procedures & Data to be Collected

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Trauma

Locations

Methodist Dallas Medical Center- Clinical Research Institute

Dallas, Texas 75203

United States